×
About 1,705 results

ALLMedicine™ Zollinger-Ellison Syndrome Center

Research & Reviews  128 results

Natural History Study of Parathyroid Disorders
https://clinicaltrials.gov/ct2/show/NCT04969926

Aug 10th, 2022 - Study Description: Patients with confirmed, suspected or at risk of developing parathyroid disorders will be provided standard of care testing for their condition. Data obtained during the testing will be used for research. Additionally, samples m...

Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome
https://clinicaltrials.gov/ct2/show/NCT00001254

Aug 9th, 2022 - This protocol concerns the approach to the localization and management of the tumor in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor and the subsequent management of the tumor.

Dermatologic Manifestations of Multiple Endocrine Neoplasia Type 1 (MEN1)
https://emedicine.medscape.com/article/1093723-print

Jul 27th, 2022 - Practice Essentials Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant familial tumor syndrome (also termed Wermer syndrome) characterized by tumors of the parathyroid glands, the enteropancreatic neuroendocrine system, the anteri...

Dermatologic Manifestations of Multiple Endocrine Neoplasia Type 1 (MEN1)
http://emedicine.medscape.com/article/1093723-overview

Jul 27th, 2022 - Practice Essentials Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant familial tumor syndrome (also termed Wermer syndrome) characterized by tumors of the parathyroid glands, the enteropancreatic neuroendocrine system, the anteri...

Dermatologic Manifestations of Multiple Endocrine Neoplasia Type 1 (MEN1)
https://emedicine.medscape.com/article/1093723-overview

Jul 27th, 2022 - Practice Essentials Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant familial tumor syndrome (also termed Wermer syndrome) characterized by tumors of the parathyroid glands, the enteropancreatic neuroendocrine system, the anteri...

see more →

Drugs  513 results see all →

Clinicaltrials.gov  15 results

Natural History Study of Parathyroid Disorders
https://clinicaltrials.gov/ct2/show/NCT04969926

Aug 10th, 2022 - Study Description: Patients with confirmed, suspected or at risk of developing parathyroid disorders will be provided standard of care testing for their condition. Data obtained during the testing will be used for research. Additionally, samples m...

Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome
https://clinicaltrials.gov/ct2/show/NCT00001254

Aug 9th, 2022 - This protocol concerns the approach to the localization and management of the tumor in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor and the subsequent management of the tumor.

YF476 and Type II Gastric Carcinoids
https://clinicaltrials.gov/ct2/show/NCT02454075

Jan 29th, 2021 - This study will evaluate whether treatment with YF476 is safe and effective in reducing the size of type II gastric carcinoid tumours, or limiting the abnormal growth of gastric ECL cells, in patients with Zollinger-Ellison syndrome.

Esomeprazole in Treatment of Early Onset Preeclampsia (ESOPE Trial)
https://clinicaltrials.gov/ct2/show/NCT03213639

Jan 7th, 2021 - The key aspects in the pathophysiology of pre-eclampsia are placental oxidative stress (and hypoxia), placental release of the anti-angiogenic factors Soluble Fms Like Tyrosine Kinase -1 and soluble endoglin and maternal endothelial dysfunction. A...

Pancreatic Exocrine Insufficiency and Pancreatic Enzyme Supplementation in Critically Ill Adult Patients
https://clinicaltrials.gov/ct2/show/NCT01753024

Sep 6th, 2018 - Critically ill patients who is able to receive early enteral nutrition and estimated to stay in ICU at least four days are considered to enroll into this study. Exclusion criteria are age under 18 or over 80 years, pregnancy or breastfeeding, know...

see more →

News  24 results

Continue, Stop, or Taper the PPI?
https://www.medscape.com/viewarticle/920314_2

Oct 25th, 2019 - My Take: It's Time for a Change. Do You Agree? The patient may not like it, but it's worth at least trying to taper his PPI at this time, with a goal of stopping regular PPI dosing altogether. Like many others, this patient is using his PPI as chr...

Improper Proton Pump Inhibitor Prescriptions Criticized
https://www.medscape.com/viewarticle/913377

May 22nd, 2019 - SAN DIEGO — Prescriptions for proton pump inhibitors (PPIs) have skyrocketed over the past 2 decades, along with concerns about inappropriate use and adverse events. Prescriptions for PPIs went from 1.6% of ambulatory care visits in 1998 to 7.6% i...

Improper Proton Pump Inhibitor Prescriptions Criticized
https://www.staging.medscape.com/viewarticle/913377

May 22nd, 2019 - SAN DIEGO — Prescriptions for proton pump inhibitors (PPIs) have skyrocketed over the past 2 decades, along with concerns about inappropriate use and adverse events. Prescriptions for PPIs went from 1.6% of ambulatory care visits in 1998 to 7.6% i...

April 2019 - Question 2
https://www.mdedge.com/gihepnews/article/197788/april-2019-question-2?channel=29259

Mar 29th, 2019 - Critique: Factors raising suspicion for Zollinger-Ellison syndrome include recurrent peptic ulcer disease, multiple ulcers, post-bulbar ulcer, non-H. pylori/non-NSAID-related duodenal ulcer, diarrhea, erosive esophagitis, and family or personal hi.

DDSEP® 8 Quick Quiz Question 2
https://www.mdedge.com/gihepnews/article/197788/ddsepr-8-quick-quiz-question-2

Mar 29th, 2019 - Critique: Factors raising suspicion for Zollinger-Ellison syndrome include recurrent peptic ulcer disease, multiple ulcers, post-bulbar ulcer, non-H. pylori/non-NSAID-related duodenal ulcer, diarrhea, erosive esophagitis, and family or personal hi.

see more →

Patient Education  2 results see all →